News Focus
News Focus
icon url

BRIG_88

02/18/14 1:15 PM

#81370 RE: MinnieM #81367

This will be interesting to watch….i have my layman's doubts about Flucide working on a wide range of viruses since they mutate so quickly they are hard to defeat as a result…..part of my skepticism comes from watching so many cancer vaccines flop and die at the hands of the FDA.
icon url

ZincFinger

02/18/14 1:37 PM

#81395 RE: MinnieM #81367

Flucide 500X better than Oseltamivir(Tamiflu)

It's clearly shown in the research: the reduction in viral load (the number of viruses circulating in the bloodstream) was 1,000 times reduced (whereas Oseltamivir(Tamiflu) reduced it a mere 2 times).

In other words the receptors on FluCide work EXTREMELY well at trapping the viruses.

It's not the ligands (the molecules that attach to the rectors) but the receptors themselves that are important.

It is very well established what receptors are important in what diseases. (thats' why they know that the CCR5 and CXCR4 receptors are very important in HIV, for example)

ALL infectious disease that are intracellular (infect INSIDE cells) must use some receptor to enter the cells. By using the specific receptors that a specific disease must use, a nanoviricide could work for any intracellular infectious disease. I suspect the reason they are working on viral targets first is that's the area where there are no effective drugs (because of viruses ability to mutate around any drug EXCEPT one that traps it by using a receptor it MUST attach to to infect. "First pick the low hanging fruit." (and "low hanging" inclused areas where there is no competition>)